Last reviewed · How we verify
Saliva Samples
At a glance
| Generic name | Saliva Samples |
|---|---|
| Sponsor | Unity Health Toronto |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- GCF and Saliva Levels of IL-36α in Periodontal Disease (NA)
- Blood Donor CVD 5000 (PHASE4)
- Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (NA)
- Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
- NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
- MIMICC Study in Patients With Colorectal Cancer (NA)
- The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (NA)
- Towards a Viral Etiology of Periodontal Disease in Relation to Radiotherapy Treatment of Head and Neck Cancers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saliva Samples CI brief — competitive landscape report
- Saliva Samples updates RSS · CI watch RSS
- Unity Health Toronto portfolio CI